Citigroup’s Tonix Pharmaceuticals TNXP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $85.8K | Buy |
6,727
+3,829
| +132% | +$49.4K | ﹤0.01% | 4768 |
|
|
2026
Q1 | $39.8K | Buy |
2,898
+2,557
| +750% | +$39.4K | ﹤0.01% | 4612 |
|
|
2025
Q4 | $5.33K | Buy |
341
+92
| +37% | +$1.7K | ﹤0.01% | 5226 |
|
|
2025
Q3 | $6.02K | Sell |
249
-2,290
| -90% | -$85K | ﹤0.01% | 5181 |
|
|
2025
Q2 | $91.4K | Buy |
2,539
+2,417
| +1,981% | +$63.3K | ﹤0.01% | 4449 |
|
|
2025
Q1 | $2.18K | Buy |
+122
| New | +$2.47K | ﹤0.01% | 5340 |
|
|
2023
Q3 | – | Hold |
0
| – | -$24 | – | 5808 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 5493 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 5957 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 6320 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 5338 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 5122 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 5108 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 5074 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 5402 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 7359 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 7627 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 7603 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 7676 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 7777 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 7804 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 7633 |
|
|
2019
Q1 | – | Hold |
0
| – | -$34K | – | 7809 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 6541 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 7437 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 7763 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 7417 |
|
|
2015
Q3 | – | Hold |
0
| – | -$1K | – | 7714 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 7338 |
|
|
2015
Q1 | – | Hold |
0
| – | -$1K | – | 7432 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 6995 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 5890 |
|
|
2014
Q1 | – | Hold |
0
| – | -$1K | – | 7206 |
|
|
2013
Q4 | – | Hold |
0
| – | – | – | 6880 |
|
Other funds holding TNXP
JHC
II
Citigroup's TNXP Position: Q2 2026 in Review
Citigroup increased its Tonix Pharmaceuticals (TNXP) stake by 132% in Q2 2026, buying an estimated $49.4K and bringing the position to 6,727 shares worth $85.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4768.
Citigroup first reported a position in TNXP in Q1 2025 and has held it in 6 quarters since. The position peaked at $91.4K in Q2 2025. 103 funds tracked by Wall St. Rank hold TNXP as of Q2 2026.
- Citigroup held 6,727 shares of Tonix Pharmaceuticals worth $85.8K as of Q2 2026.
- Citigroup bought 3,829 Tonix Pharmaceuticals shares in Q2 2026, an estimated $49.4K.
- Tonix Pharmaceuticals made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #4768 holding.
- Citigroup first reported a position in Tonix Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
- Citigroup's Tonix Pharmaceuticals position peaked at $91.4K in Q2 2025.
- 103 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q2 2026.
Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.